6 results found.

1. Adding Radioimmunotherapy To Chemotherapy Reduces Relapse Risk In Mantle Cell Leukemia Patients

... Non-Hodgkins Lymphoma News- Return to News Menu Adding Radioimmunotherapy To Chemotherapy Reduces Relapse Risk In Mantle Cell Leukemia Patients Category: Lymphoma/Leukemia News 18 December 2005- A new cancer treatment that combines the power of ...

Score: 16 - 15 Oct 2006 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/non-hodgkins-news0019.htm

2. Zevalin (Rituxin) Scan and Treatment

... Non-Hodgkins Lymphoma News- Return to News Menu Clinical History This is a 51-year-old male with relapse of refractory low-grade, non-Hodgkin's lymphoma. Technique In the Cancer Center treatment room, the patient was infused with Rituxin ( ...

Score: 7 - 31 Aug 2007 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/nhl-news0014.htm

3. Added Rituxan® Improves Initial Treatment of Follicular Lymphoma with CVP

... % Complete Response Rate 41% 11% Stable Disease 21% 7% Progressive Disease 16% 10% Relapse after Response 37% 54% Time to Treatment Failure 27 months 7 months Time to New Therapy Not ...

Score: 3 - 15 Oct 2006 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/nhl-news0010.htm

4. Non-Hodgkins Lymphoma (NHL) News Items and Press Releases

... to chemotherapy, which is what happened with Cole," his mother said. Adding Radioimmunotherapy To Chemotherapy Reduces Relapse Risk In Mantle Cell Leukemia Patients A new cancer treatment that combines the power of radioactive monoclonal antibodies with ...

Score: 3 - 31 Aug 2007 - URL: http://www.non-hodgkins-lymphoma-cancer.org/non-hodgkins-lymphoma-news.htm

5. Parent cancer group formed to investigate cases of lymphoma

... NHL patients, is a slow developing but serious cancer of the lymphatic system, and patients are prone to relapse after treatment. “ This approval for MabThera marks a major advance in the treatment of indolent NHL, ...

Score: 3 - 15 Oct 2006 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/nhl-news0005.htm

6. MabThera maintenance therapy dramatically improves survival for patients with lymphoma

... months 0.0043 46% 2 Treatment effect of maintenance therapy reduction in the risk of progression of the disease, relapse or death About Non-Hodgkin ’ s Lymphoma Non-Hodgkin ’ s lymphoma (NHL) affects 1.5 million people worldwide ...

Score: 2 - 31 Aug 2007 - URL: http://www.non-hodgkins-lymphoma-cancer.org/news/non-hodgkins-news0023.htm